Literature DB >> 1932575

The solution structure of the lantibiotic gallidermin.

S Freund1, G Jung, O Gutbrod, G Folkers, W A Gibbons, H Allgaier, R Werner.   

Abstract

The 21-peptide amide antibiotic gallidermin is a potential therapeutic against acne disease. It belongs to the class of polycyclic lanthionine and alpha,beta-didehydroamino acids containing polypeptides, which were named "lantibiotics." The structural gene of the recently elucidated lantibiotic gallidermin encodes a precursor peptide containing Ser, Thr, and Cys residues in the C-terminal prolantibiotic part, and an unusually hydrophilic leader peptide. The ribosomally synthesized pregallidermin is posttranslationally modified and processed to a complex peptide antibiotic with four sulfide rings and two unsaturated residues. The complete solution structure of gallidermin was determined in trifluoroethanol: water (95:5) and dimethylsulfoxide by two-dimensional 1H-nmr at 500 MHz, using a combination of double quantum filtered correlated spectroscopy, homonuclear Hartman-Hahn, and nuclear Overhauser enhancement spectroscopy experiments. Using a total number of 152 distance constraints from NOEs and 14 torsional constraints, derived from coupling constants, we obtained a screwlike solution structure of gallidermin. Restrained molecular dynamics simulations yielded a set of five converging structures with an atomic rms difference of 1.7 A for the backbone atoms, not dependent on the starting structure. The spatial structure model is in excellent agreement with the amphiphilic and channel-forming properties of gallidermin on membranes and its tryptic cleavage at the exposed site between residues 13 and 14.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1932575     DOI: 10.1002/bip.360310626

Source DB:  PubMed          Journal:  Biopolymers        ISSN: 0006-3525            Impact factor:   2.505


  11 in total

1.  Insights into in vivo activities of lantibiotics from gallidermin and epidermin mode-of-action studies.

Authors:  Raquel Regina Bonelli; Tanja Schneider; Hans-Georg Sahl; Imke Wiedemann
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

Review 2.  Structures of lantibiotics studied by NMR.

Authors:  F J van De Ven; G Jung
Journal:  Antonie Van Leeuwenhoek       Date:  1996-02       Impact factor: 2.271

3.  Activity of gallidermin on Staphylococcus aureus and Staphylococcus epidermidis biofilms.

Authors:  Jongkon Saising; Linda Dube; Anne-Kathrin Ziebandt; Supayang Piyawan Voravuthikunchai; Mulugeta Nega; Friedrich Götz
Journal:  Antimicrob Agents Chemother       Date:  2012-08-27       Impact factor: 5.191

4.  A quantum-mechanical study of the chain-length dependent stability of the extended and 3(10)-helix conformations in dehydroalanine oligopeptides.

Authors:  J Casanovas; C Alemán
Journal:  J Comput Aided Mol Des       Date:  1994-08       Impact factor: 3.686

5.  Isolation and identification of a Paenibacillus polymyxa strain that coproduces a novel lantibiotic and polymyxin.

Authors:  Zengguo He; Duygu Kisla; Liwen Zhang; Chunhua Yuan; Kari B Green-Church; Ahmed E Yousef
Journal:  Appl Environ Microbiol       Date:  2006-10-27       Impact factor: 4.792

6.  Characterization of the Antimicrobial Peptide Penisin, a Class Ia Novel Lantibiotic from Paenibacillus sp. Strain A3.

Authors:  Piyush Baindara; Vasvi Chaudhry; Garima Mittal; Luciano M Liao; Carolina O Matos; Neeraj Khatri; Octavio L Franco; Prabhu B Patil; Suresh Korpole
Journal:  Antimicrob Agents Chemother       Date:  2015-11-16       Impact factor: 5.191

7.  Isolation and characterization of genetically engineered gallidermin and epidermin analogs.

Authors:  B Ottenwälder; T Kupke; S Brecht; V Gnau; J Metzger; G Jung; F Götz
Journal:  Appl Environ Microbiol       Date:  1995-11       Impact factor: 4.792

8.  Engineering of a novel thioether bridge and role of modified residues in the lantibiotic Pep5.

Authors:  G Bierbaum; C Szekat; M Josten; C Heidrich; C Kempter; G Jung; H G Sahl
Journal:  Appl Environ Microbiol       Date:  1996-02       Impact factor: 4.792

Review 9.  Bacteriocins of gram-positive bacteria.

Authors:  R W Jack; J R Tagg; B Ray
Journal:  Microbiol Rev       Date:  1995-06

Review 10.  Lanthipeptides: chemical synthesis versus in vivo biosynthesis as tools for pharmaceutical production.

Authors:  Elvis Legala Ongey; Peter Neubauer
Journal:  Microb Cell Fact       Date:  2016-06-07       Impact factor: 5.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.